The HCPLive conference coverage page features articles, videos, and expert-led live coverage from major medical meetings throughout the year.
Don't Miss a Beat: SELECT, DAPA-MI, & AHA 2023
November 13th 2023In this episode, hosts sit down between sessions at AHA 2023 to discuss the landmark SELECT trial, their interpretation of the data, and its implications for care moving forward. Later in the episode, hosts break down the DAPA-MI trial.
History of Hepatocellular Carcinoma Increases Risk of Liver-Related Mortality After SVR
November 13th 2023Results from this prospective study in Japan found older age, history of hepatocellular carcinoma, and decreased albumin level at SVR were significantly associated with liver-related mortality after SVR.
Food Insecurity, Household Income Associated with Risk of NAFLD in Adolescents
November 12th 2023Results presented at The Liver Meeting 2023 from the American Association for the Study of Liver Diseases highlighted an association between food insecurity and low household income with the risk of NAFLD in adolescents.
Quality of Life Is Worse for Patients with Heart Failure than Many Cancers, Study Finds
November 12th 2023Participants with heart failure measured lower on physical and mental component scores than patients with lung, colon, breast, or prostate cancer, highlighting their worser health-related quality of life.
Seladelpar Improves Markers of Cholestasis, Pruritus in Patients with PBC
November 12th 2023Phase 3 data presented at The Liver Meeting 2023 from the American Association for the Study of Liver Diseases demonstrated the safety and efficacy of seladelpar in patients with primary biliary cholangitis through 12 months of treatment.
Abelacimab Significantly Reduces Bleeding in People with Atrial Fibrillation, Study Finds
November 12th 2023Presented at AHA 2023, the topline analysis of the phase 2 AZALEA-TIMI 71 trial showed abelacimab significantly reduced bleeding in people with Afib at risk of stroke, compared with rivaroxaban.